Skip to content

    Ovarian Cancer

    Trial name
    CATALINA-2
    A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

    Description
    A Phase 2 Study Evaluating the Efficacy and Safety of TORL-1-23 in Women With Advanced Platinum-Resistant Epithelial Ovarian Cancer (Including Primary Peritoneal and Fallopian Tube Cancers) Expressing Claudin 6

    Trial code: NCT06690775


    Share
    Top